Skip to main content
Premium Trial:

Request an Annual Quote

Gentris Scores $5M VC Investment from Mitsui

NEW YORK, April 27 (GenomeWeb News) - Gentris has closed a $5 million funding round with Mitsui USA, the company said today. 


Gentris said that the new funding would allow it to continue to develop and distribute pharmacogenomic diagnostic testing kits.


The investment came one month after the FDA released it pharmacogenomics guidance, which Yoshi Maruoka, a senior vice president at Mitsui USA, said encouraged his company to invest in Gentris.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.